What Do Analysts Think Of Opko Health Inc (NASDAQ:OPK)?

Josh Kim
Сентября 15, 2016

(Under Special Management) has 2.4% invested in the company for 3.12 million shares.

On Tuesday, August 16th, Phillip Md Et Al Frost acquired 10,000 shares of Opko Health stock. Frost Phillip Md Et Al accumulated 10,000 shares in the company at a per-share price of $9.79 and ended up spending $97,900 in the investment.

On Monday, September 12th, Phillip Md Et Al Frost bought 10,000 shares of Opko Health stock. The shares were bought at an average price of $10.02 per share, for a total transaction of $100,200.00. Frost Phillip Md Et Al now have 183,000,000 shares in the stock after this transaction.

On Thursday, August 25th, Phillip Md Et Al Frost acquired 48,400 shares of Opko Health stock. In this transaction, these shares were bought at value of $9.95 per share, according to the information disclosed by the Securities and Exchange Commission in a Form 4 filing on 01 Sep 2014.

On Wednesday, August 24th, Phillip Md Et Al Frost bought 15,000 shares of Opko Health stock. The shares were bought at an average price of $9.24 per share, for a total transaction of $138,600.00.

On Tuesday, August 23rd, Phillip Md Et Al Frost bought 29,000 shares of Opko Health stock. The shares were bought at an average price of $9.53 per share, for a total transaction of $276,370.00.

On Monday, August 22nd, Phillip Md Et Al Frost bought 11,800 shares of Opko Health stock.

On Friday, August 19th, Phillip Md Et Al Frost acquired 15,000 shares of Opko Health stock. The shares were acquired at an average price of $9.82 per share, with a total value of $147,300.00.

Читайте также: What do Analysts Say about: MannKind Corporation (NASDAQ:MNKD)

On Thursday, August 18th, Phillip Md Et Al Frost acquired 10,000 shares of Opko Health stock. The shares were bought at an average price of $9.87 per share, for a total transaction of $98,700.00.

On Wednesday, August 17th, Phillip Md Et Al Frost acquired 10,000 shares of Opko Health stock. The shares were bought at an average price of $9.90 per share, for a total transaction of $99,000.00. The ratio increased, as 33 funds sold all Opko Health Inc. shares owned while 63 reduced positions. (NYSE:OPK) opened at 10.19 on Thursday.

Many analysts are providing their Estimated Earnings analysis for Opko Health Inc and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.02/share.

Price to Sale ratio of 90 stands at 5.03 while Price to Book Ratio stands at 2.65. Opko Health Inc. (NASDAQ:OPK)'s distance from 20 day simple moving average is 6.63% whereas its distance from 50 day simple moving average is 4.15% along with 4.11% distance from 200 day simple moving average. In contrast to the year ago quarter EPS was at 0.08. During the same period in the previous year, the business posted ($0.09) earnings per share. Opko Health's revenue was up 742.2% on a year-over-year basis.

While looking at the Stock's Performance, Opko Health Inc now shows a Weekly Performance of 6.26%, where Monthly Performance is 1.09%, Quarterly performance is 10.4%, 6 Months performance is -0.39% and yearly performance percentage is -1.36%.

Several equities research analysts recently commented on the company. 2 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of Opko Health Inc (NASDAQ:OPK) stands at 76.76 while the industry's and the sector's growth for next 5 years ticked at 10.93 and 11.21 respectively. High potential price target is set at $22.00 however minimum price target advised by analysts is $10.00. Oppenheimer Holdings Inc. restated an "outperform" rating on shares of Opko Health in a research note on Saturday, June 25th. Finally, Standpoint Research assumed coverage on shares of Opko Health in a research report on Friday, June 3rd. They now have a United States dollars 16 price target on the stock. Five investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company.

При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2019 Copyright.
Автоматизированное извлечение информации сайта запрещено.

Код для вставки в блог

Other reports by

Discuss This Article